Sign in

CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company

BICYCLE THERAPEUTICS PLC

Sign in to watch
Ticker
BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
011441223261503
Business address
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
Former names
BICYCLE THERAPEUTICS Ltd
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 8-K Event Other events
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 8-K Event Executive or director change
  12. 4 Grant or award Director acquired 5,750 shares (grant or award)
  13. 4 Grant or award Director acquired 5,750 shares (grant or award)
  14. 4 Open-market sale Chief Business Officer sold 1,801 shares at $29.06 ($52,337)
  15. 4 Open-market sale Chief Operating Officer sold 1,801 shares at $29.06 ($52,337)
  16. 4 Open-market sale Chief Medical Officer sold 1,801 shares at $29.06 ($52,337)
  17. 4 Open-market sale Chief Technology Officer sold 1,801 shares at $29.06 ($52,337)
  18. 4 Open-market sale Chief Scientific Officer sold 1,817 shares at $29.06 ($52,802)
  19. 4 Open-market sale President and CFO sold 1,815 shares at $29.06 ($52,744)
  20. 4 Grant or award Director acquired 5,750 shares (grant or award)

Page 19 of 33 · 660 filings